Stay updated with breaking news from Mark Rothera. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mark Rothera, President and CEO of Silence Therapeutics PLC talks to Proactive about their new deal with one of China’s biggest drug...
Investegate announcements from Silence Therapeutics, Proposed Cancellation of Trading on AIM
Investegate announcements from Silence Therapeutics, Silence and Hansoh Pharma Announce Collaboration
In a separate announcement, Silence said it was cancelling its listing on London’s AIM market to make Nasdaq its primary listing
Under the terms of the agreement, Hansoh will make a $16m upfront payment to Silence - News - PharmaTimes